Quarterly Activities Report
Sydney, Nov 1, 2018 AEST (ABN Newswire) - Queensland Bauxite Ltd (
ASX:QBL) provides the Company's Quarterly Activities Report.
Quarter Highlights:
19th July: Medcan secures ODC Import/Export License
1st August: Groundbreaking Discovery in Medicinal Cannabis Research
16th August: QBL to acquire International Health Food Brands
14th September: Company E.G.M.
30th September: End of Quarter
9th October: Medcan secures ODC Medical Cannabis Manufacture License
19th October: Joint venture with leading Israeli medicinal cannabis company, Pharmocann
24th October: Medcan secures strategic collaboration supply agreement with Canadian LP, Bonify
To view the full report, please visit:
http://abnnewswire.net/lnk/7SP54DP5
About Queensland Bauxite Ltd
Queensland Bauxite Limited (ASX:QBL) is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company's lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has agreed to acquire a 100% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries, and a 100% shareholding in Medcan Australia Pty Ltd, a company with an ODC cultivation and production License and a DA approved Cannabis production and manufacturing facility.
| ||
|
